✨ Free AI Report
DNAnexus, Inc.: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research DNAnexus, Inc.
Company Research

DNAnexus, Inc.: Business Overview, Financials & Competitive Analysis

DNAnexus, Inc. scores 8/10 on the AskCyborg Cyborg Score (Strong). DNAnexus is a capital-efficient platform company enabling the monetization of genomic data at scale, with established product-market fit and blue-chip investor backing in an expanding precision medicine ecosystem. DNAnexus combines deep technical expertise in genomics informatics with substantial institutional capital ($666M+ raised from tier-one investors including Blackstone, Google Ventures, and.

What is DNAnexus, Inc.'s industry? DNAnexus, Inc. (dnanexus.com) operates in Bioinformatics. AskCyborg classifies DNAnexus, Inc. under Bioinformatics in its company registry.

DNAnexus is a provider of cloud-based genome informatics and data management platform that enables enterprises and organizations in genomic medicine to analyze raw sequencing data, integrate genomic data with clinical...

8/ 10Strong

Cyborg Score thesis

DNAnexus is a capital-efficient platform company enabling the monetization of genomic data at scale, with established...

Read the full analyst-debate transcript →
Industry Bioinformatics
4 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: September 7, 2026
AI-Verified Research
30+ Page Report

Get the Latest DNAnexus, Inc. Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Analyst-debate audio for DNAnexus, Inc.

AskCyborg analysts argue the bull and bear cases for DNAnexus, Inc. across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
DNAnexus, Inc. OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below

DNAnexus, Inc. Overview

Pro stress-test →

DNAnexus is a provider of cloud-based genome informatics and data management platform that enables enterprises and organizations in genomic medicine to analyze raw sequencing data, integrate genomic data with clinical and phenotypic information, and collaborate seamlessly. The company addresses a critical bottleneck in precision medicine: geneticists predict more than 500 million genomes will be sequenced by 2025 generating 40 exabytes of data, but only a fraction is currently utilized for drug discovery.

Strategic Profile

Pro stress-test →

DNAnexus has raised $473M in funding from investors like Google Ventures, TPG and First Round Capital, with its most recent major financing being a Series H round for $200M in March 2022 led by Blackstone. The company ranks 2nd among 355 active competitors and 2nd in terms of total funding among its peers, positioning it as a well-capitalized leader in biomedical data infrastructure for the life sciences industry.

Competitive Landscape

Pro stress-test →

DNAnexus's top competitors include Evotec, Insitro, and Fabric Genomics. Additional competitors include Partek, Benchling, InterpretOmics, PointCross Life Sciences, and Golden Helix. These competitors span different segments of the genomic data workflow—some focus on software platforms, others on specialized analytics—but DNAnexus's breadth across data management, analytics, and collaboration gives it competitive leverage in enterprise life sciences accounts.

Industry Context

DNAnexus, Inc. operates in Bioinformatics.

Key facts

Founded: 2009 · Headquarters: Mountain View, US · Employees: 277 · Revenue: Estimated $50M–$100M · Market cap: N/A

What the analysts stress-tested

The top findings that survived the multi-agent debate for DNAnexus, Inc..

  • DNAnexus has secured $666M in total funding over 11 rounds as of mid-2026, demonstrating sustained institutional confidence in its platform. The majority of the company's capitalization came from the March 2022 Series H round, indicating the market recognizes DNAnexus as a critical infrastructure layer for the genomics economy.
  • The platform operates as a secure, collaborative environment enabling pharmaceutical, diagnostic, and research organizations to manage multi-omics and clinical data using AI/ML-powered analytics. This positions DNAnexus at the intersection of healthcare IT and advanced analytics—markets experiencing 15-20% annual growth.
+1 more stress-tested counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • April 2026Employee count reached 277 as of latest count
  • March 2022Series H funding round closed for $200M led by Blackstone Growth
  • +1 moreTrack every material event for DNAnexus, Inc. as it happens. Explore monitoring →
Get alerted when DNAnexus, Inc. has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

BenchlingCloud-based laboratory informatics and genomics platform→Golden HelixGenomic analysis and visualization software→CongenicaGenomic analysis and interpretation platform→LatchBioinformatics workflow and data management platform→

Compare DNAnexus, Inc. with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

DNAnexus, Inc. operates in Bioinformatics. See how the rest of the sector scores on the Cyborg framework.

Browse Bioinformatics research →
NEW · MCP server

Ask your AI assistant about DNAnexus, Inc.

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare DNAnexus, Inc. and its top competitor on Cyborg Score”
“What did DNAnexus, Inc. do this quarter?”
“Is DNAnexus, Inc. a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg builds confidence

⚔

Analyst debate, not single-author opinion

Every report is stress-tested by a panel of AI analysts arguing across 11 dimensions. The output is the part of the case that survived pushback.

📊

Recalibrated weekly

The Cyborg Score is recomputed weekly against fresh data. Recent material developments are continuously tracked and surfaced.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The same company gets the same score from any analyst running the framework.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, news flow, and proprietary analyst signals. Read the methodology →

Frequently asked questions

What does DNAnexus, Inc. do?+
DNAnexus is a provider of cloud-based genome informatics and data management platform that enables enterprises and organizations in genomic medicine to analyze raw sequencing data, integrate genomic data with clinical...
What is DNAnexus, Inc.'s Cyborg Score?+
DNAnexus, Inc. has a Cyborg Score of 8/10 (Strong). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are DNAnexus, Inc.'s main competitors?+
Named competitors include Benchling, Golden Helix, Congenica, Latch. The full competitive landscape is in the AskCyborg report.
How can I get the full DNAnexus, Inc. research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the DNAnexus, Inc. research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track DNAnexus, Inc. over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

More Bioinformatics research

Companies in the same sector and named competitors, ranked by Cyborg Score.

5Latch, Inc.